Groupe Rocher partners with Dassault Systèmes to accelerate cosmetics innovation using virtual twin technology

hVIVO signs influenza human challenge trial agreement with Traws Pharma

IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination

Hoth Therapeutics reports positive HT-VA CRADA data

Kelun-Biotech reports Phase II study results for sac-TMT at 2026 SGO

Genmab reports positive safety data for Rina-S combination in ovarian cancer

GSK reports strong early-stage data for B7-H4 ADC in gynaecological cancers

FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer

Almirall expands supercomputing and AI collaboration with Barcelona Supercomputing Center

Qlucore launches AI-based AML test

EU approves Sanofi and Regeneron's Dupixent for young children with chronic spontaneous urticaria

Haisco Pharmaceutical signs global pain‑drug licensing deal with AbbVie

AnBogen Therapeutics to present Imofinostat (ABT-301) breakthroughs at AACR 2026

Verastem Oncology presents two-year follow-up data on avutometinib and defactinib in recurrent low-grade serous ovarian cancer

DualityBio reports China NMPA acceptance of BLA for T-Pam for treatment of unresectable or metastatic HER2-positive breast cancer